AU647599B2 - New thiazolidinone and oxazolidinone derivatives, their preparation and their use as vasodilators - Google Patents

New thiazolidinone and oxazolidinone derivatives, their preparation and their use as vasodilators Download PDF

Info

Publication number
AU647599B2
AU647599B2 AU13122/92A AU1312292A AU647599B2 AU 647599 B2 AU647599 B2 AU 647599B2 AU 13122/92 A AU13122/92 A AU 13122/92A AU 1312292 A AU1312292 A AU 1312292A AU 647599 B2 AU647599 B2 AU 647599B2
Authority
AU
Australia
Prior art keywords
group
carbon atoms
groups
formula
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU13122/92A
Other languages
English (en)
Other versions
AU1312292A (en
Inventor
Sadao Ishihara
Hiroyuki Koike
Sigeki Miyake
Hiroshi Mizuno
Fujio Saito
Takao Yoshioka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of AU1312292A publication Critical patent/AU1312292A/en
Application granted granted Critical
Publication of AU647599B2 publication Critical patent/AU647599B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Indole Compounds (AREA)
AU13122/92A 1991-03-27 1992-03-24 New thiazolidinone and oxazolidinone derivatives, their preparation and their use as vasodilators Ceased AU647599B2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP3-63088 1991-03-27
JP6308891 1991-03-27
JP3-102751 1991-05-08
JP10275191 1991-05-08
JP3-330304 1991-12-13
JP33030491 1991-12-13

Publications (2)

Publication Number Publication Date
AU1312292A AU1312292A (en) 1992-10-01
AU647599B2 true AU647599B2 (en) 1994-03-24

Family

ID=27298042

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13122/92A Ceased AU647599B2 (en) 1991-03-27 1992-03-24 New thiazolidinone and oxazolidinone derivatives, their preparation and their use as vasodilators

Country Status (23)

Country Link
US (2) US5298516A (OSRAM)
EP (1) EP0506434B1 (OSRAM)
JP (1) JPH0780859B2 (OSRAM)
KR (1) KR0152097B1 (OSRAM)
CN (2) CN1031824C (OSRAM)
AT (1) ATE118770T1 (OSRAM)
AU (1) AU647599B2 (OSRAM)
CA (1) CA2064108C (OSRAM)
CZ (1) CZ282529B6 (OSRAM)
DE (1) DE69201451T2 (OSRAM)
DK (1) DK0506434T3 (OSRAM)
ES (1) ES2072095T3 (OSRAM)
FI (1) FI106260B (OSRAM)
HK (1) HK123595A (OSRAM)
HU (2) HU217969B (OSRAM)
IE (1) IE67383B1 (OSRAM)
IL (1) IL101395A (OSRAM)
IS (1) IS1746B (OSRAM)
NO (1) NO304311B1 (OSRAM)
NZ (1) NZ242154A (OSRAM)
PH (1) PH30493A (OSRAM)
RU (1) RU2055073C1 (OSRAM)
TW (1) TW226015B (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3454531B2 (ja) * 1991-11-07 2003-10-06 三共株式会社 ニトロキシアルキルアミド誘導体
EP0689435A1 (de) * 1993-03-15 1996-01-03 Byk Nederland Bv Verwendung von substituierten alkylnitraten zur behandlung des krankhaft erhöhten augeninnendruckes
DE4429461A1 (de) * 1994-08-19 1996-02-22 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
CA2207794A1 (en) * 1994-12-15 1996-06-20 Sankyo Company, Limited Thiazolidinone compounds or angina pectoris remedy or preventive containing the same as active ingredient
CZ290989B6 (cs) * 1995-03-02 2002-11-13 Sankyo Company, Limited Opticky aktivní thiazolidinonový derivát, prostředek jej obsahující, pouľití tohoto derivátu a způsob jeho přípravy
US5925658A (en) * 1995-03-02 1999-07-20 Sankyo Company, Limited Optically active thiazolidinone derivative
WO1997000239A1 (fr) * 1995-06-14 1997-01-03 Sankyo Company, Limited Medicament contre l'angine contenant un derive nitroxy comme ingredient actif
BE1010768A3 (nl) * 1996-11-26 1999-01-05 Dsm Nv Een werkwijze voor de bereiding van alpha-aminozuuramiden, alpha-aminozuren en derivaten ervan.
IL120531A (en) * 1997-03-26 2006-12-31 Yissum Res Dev Co Nitric oxide donors and pharmaceutical compositions containing them
WO2002069967A1 (en) * 2001-03-01 2002-09-12 Sankyo Company, Limited Percutaneous absorption compositions
WO2013016727A1 (en) * 2011-07-28 2013-01-31 Promentis Pharmaceuticals, Inc. Cysteine prodrugs
US10239847B1 (en) 2016-03-03 2019-03-26 Cellactin Method for 2-oxothiazolidine-4-carboxylic acid for cellular glutathione

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5655490A (en) * 1989-04-21 1990-11-16 E.I. Du Pont De Nemours And Company Fungicidal oxazolidinones

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200640A (en) * 1976-04-02 1980-04-29 Chugai Seiyaku Kabushiki Kaisha Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use
GB8717068D0 (en) * 1987-07-20 1987-08-26 Fujisawa Pharmaceutical Co Nitric ester derivative

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5655490A (en) * 1989-04-21 1990-11-16 E.I. Du Pont De Nemours And Company Fungicidal oxazolidinones

Also Published As

Publication number Publication date
EP0506434B1 (en) 1995-02-22
HU211969A9 (en) 1996-01-29
US5298516A (en) 1994-03-29
US5356918A (en) 1994-10-18
DE69201451T2 (de) 1995-10-12
KR920018036A (ko) 1992-10-21
HUT68242A (en) 1995-06-28
ES2072095T3 (es) 1995-07-01
HU217969B (hu) 2000-05-28
CN1066067A (zh) 1992-11-11
EP0506434A1 (en) 1992-09-30
FI921340A0 (fi) 1992-03-26
TW226015B (OSRAM) 1994-07-01
HK123595A (en) 1995-08-04
IS3828A (is) 1992-09-28
IL101395A0 (en) 1992-11-15
CN1113435A (zh) 1995-12-20
CZ282529B6 (cs) 1997-08-13
IE920966A1 (en) 1992-10-07
IL101395A (en) 1996-10-16
CN1031824C (zh) 1996-05-22
NO921159L (no) 1992-09-28
RU2055073C1 (ru) 1996-02-27
HU9201033D0 (en) 1992-06-29
CZ91692A3 (en) 1993-01-13
AU1312292A (en) 1992-10-01
FI921340L (fi) 1992-09-28
CA2064108C (en) 2000-09-26
FI106260B (fi) 2000-12-29
JPH05213910A (ja) 1993-08-24
DE69201451D1 (de) 1995-03-30
JPH0780859B2 (ja) 1995-08-30
CA2064108A1 (en) 1992-09-28
CN1096265C (zh) 2002-12-18
PH30493A (en) 1997-05-28
DK0506434T3 (da) 1995-07-24
NO304311B1 (no) 1998-11-30
IE67383B1 (en) 1996-03-20
ATE118770T1 (de) 1995-03-15
KR0152097B1 (ko) 1998-10-15
NO921159D0 (no) 1992-03-25
IS1746B (is) 2000-07-11
NZ242154A (en) 1993-09-27

Similar Documents

Publication Publication Date Title
CA2348741C (en) Nitrosasted and nitrosylated nonsteroidal antiinflammatory compounds, comositions and methods of use
CA2446136C (en) Pyruvate derivatives
US5356918A (en) Oxazolidinone compounds and method of using the same as a vasodilator
ES2462292T3 (es) Derivados de amida
AU701977B2 (en) Optically active thiazolidinone derivative
CZ282427B6 (cs) Deriváty aminokyselin, způsob výroby a farmaceutické prostředky s jejich obsahem
KR100230633B1 (ko) 니트록시알킬아미드 유도체(Nitroxyalkylamide derivate)
EP0039919B1 (en) Benzoxazole and benzothiazole derivatives with anti-allergic activity
EP0903346A1 (en) Sydnone imine derivatives
US5891898A (en) Method for treating or preventing ulcerative diseases by administering thia- or oxazolidinone compounds
JP4199314B2 (ja) シドノンイミン誘導体
CA2359031C (en) Thiazolidinone or oxazolidinone derivatives for treatment of ulcerative disease
AU712883B2 (en) Optically active thiazolidinone derivatives
CZ2001798A3 (en) Use of thia- or oxazolidinone derivatives for preparing a medicament for therapy or prevention of ulcer diseases